Abstract: Enzyme-triggered self-reacting arm compounds and chemical intermediates used for preparing such compounds and uses thereof, specifically in prodrug design and conjugation technologies. A Ligand-Drug-Conjugate (LDC) includes such enzyme-triggered self-reacting arms.
Type:
Application
Filed:
March 30, 2022
Publication date:
July 4, 2024
Applicants:
MABLINK BIOSCIENCE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS -, UNIVERSITE CLAUDE BERNARD LYON 1
Inventors:
Warren VIRICEL, BenoƮt JOSEPH, Guy FOURNET